780
Participants
Start Date
August 29, 2017
Primary Completion Date
July 7, 2021
Study Completion Date
July 7, 2021
Indacaterol/Glycopyrrolate
27.5/15.6 mcg active indacaterol/glycopyrrolate
Placebo
27.5/15.6 mcg placebo
Cornell University, New York
University of Pittsburgh, Pittsburgh
Temple University, Philadelphia
Johns Hopkins University, Baltimore
Duke University, Durham
Universityof Alabama, Birmingham
University of Michigan, Ann Arbor
University of Iowa, Iowa City
Minnesota Health partners, Saint Paul
Minneapolis VA Medical Center, Minneapolis
University of Illinois, Chicago
Northwestern University, Chicago
University of Utah, Salt Lake City
University of California, Los Angeles
LABIOMED at Harbor-UCLA Medical Center, Torrance
University of California, San Francisco
National Heart, Lung, and Blood Institute (NHLBI)
NIH
University of Michigan
OTHER